Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia - Test2 - elhamkhani - TriplyDB

Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia

Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia

http://www.wikidata.org/entity/Q24245915

about

Anticholinergics for neuroleptic-induced parkinsonism and tardive dyskinesia Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia Calcium channel blockers for neuroleptic-induced tardive dyskinesia Miscellaneous treatments for neuroleptic-induced tardive dyskinesia Tardive dyskinesia in patients treated with atypical antipsychotics: case series and brief review of etiologic and treatment considerations.Vitamin E for antipsychotic-induced tardive dyskinesia.

P2860

Q24193307-D16B2AE7-0080-41EA-990F-25EFD0280233 Q24235122-569B91F1-329C-462C-8477-3E065EF22C6B Q24235247-2823C75A-B97E-4610-95F5-433FD7B8D9A6 Q24248650-3C065225-9741-4F8A-832E-1B314C99B008 Q37707292-77171585-999A-4A4F-A74F-1DE0E41C07E1 Q47555034-0440CEB5-6BFA-4ED3-B8BB-3DAEB68EA2EC

P2860

Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia

http://www.wikidata.org/entity/Q24245915

description

2004 nî lūn-bûn

@nan

2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia

@ast

Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia

@en

Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia

@en-gb

Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia

@nl

type

label

Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia

@ast

Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia

@en

Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia

@en-gb

Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia

@nl

prefLabel

Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia

@ast

Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia

@en

Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia

@en-gb

Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia

@nl

P1433

Q24245915-C0F2BB55-496B-4799-B5AB-3FBC65A52083

P1476

Q24245915-6814E3F8-1032-4DAA-AFEA-579683BD15BF

P2093

Q24245915-9A4D9E6B-FA8C-497A-BE1B-B56D0F1D527E

P2860

Q24245915-02DACAC7-1AED-43D6-AF1C-8F00AACD1101

Q24245915-04489ED2-4F87-4DD7-8B90-536D2D2C8BE9

Q24245915-1CBAD710-6C0A-4EBA-BE63-2C9D475ABF4E

Q24245915-207D0FE8-1CCC-44FD-B39A-376ECB896CCF

Q24245915-4311804D-040D-4FF8-B423-CFAE1B4442A7

Q24245915-452BF720-C884-43BB-99AA-B7FF5CCDAC4F

Q24245915-4787F2F7-B2BF-4D61-B1D5-2EB06ABE55A4

Q24245915-4B506D59-4D2F-4503-9253-B772ED2FDCEF

Q24245915-4D2F13BF-98E8-40BA-BBE1-BA58BB6BD405

Q24245915-540A2A6C-09F6-4A30-8707-A89229FD7B05

P304

Q24245915-56F0B495-D617-4B0E-8AE1-9A38DBB4AB2C

P31

Q24245915-07EA2232-3AB5-4D68-B3FA-DF287C9C0353

Q24245915-5056798c-06cf-43ab-98f9-2ca52ce8a0fe

P356

Q24245915-5C950805-A8CD-4FEF-94F8-D6BEFC41610B

P407

Q24245915-AA89D6EF-8B85-49B5-B4A7-AEEBDAA4B1B5

P433

Q24245915-2160E6AD-95D0-4005-B68B-7FF29E5686E3

P50

Q24245915-5AE9272E-A208-4814-AD60-EAB199DBFB52

Q24245915-E6FF78FD-48AF-4590-9EF9-D93743864DF9

P577

Q24245915-1A57976F-E034-4164-B705-CF3E3F05686C

P698

Q24245915-6D1D16E2-7178-4493-B483-5BBDCF306A67

P921

Q24245915-967AD0E6-2E12-425B-BD05-FCC0EAB920AD

P356

14651858.CD000203.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia

@en

P2093

John Rathbone

http://www.w3.org/2001/XMLSchema#string

P2860

Bias in meta-analysis detected by a simple, graphical test

Measuring inconsistency in meta-analyses

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

Anticonvulsants as adjuncts for the neuroleptic treatment of schizophrenic psychoses: a clinical study with beclamide

Baclofen (Lioresal) in the treatment ofneuroleptic-induced tardive dyskinesia

The relationship between parkinsonism and tardive dyskinesia

Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994.

A comparison of purposeless movements in psychiatric patients treated with antipsychotic drugs, and normal individuals

Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia.

Sodium valproate and biperiden in neuroleptic-induced akathisia, parkinsonism and hyperkinesia. A double-blind cross-over study with placebo.

P304

CD000203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/14651858.CD000203.PUB2

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P50

Karla Soares-Weiser

P577

2004-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15494993

http://www.w3.org/2001/XMLSchema#string

P921